“…They also indicated that each trial had its own selection criteria, which left them to focus on one or two individual trials, neglect other trials, and seek patients who fit the criteria for the specific trials they selected. Mozelak, Glassman, and Johnston (2001) concluded that significant problems exist in enrolling cancer patients for clinical trials because of the need to manage increasing volumes of data and track the rapidly evolving inclusion and exclusion heuristics for each trial.…”